Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nicholas Kenney

Sports Medicine La Grange, KY Medical Doctor

NPI 1558564633 CMS profile 251591

1023 New Moody Ln, Suite 102, La Grange, KY 40031

Open in the dashboard

General payments

$8,248

63 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicholas Kenney of La Grange, KY is reported in the CMS Open Payments database as having received $8,248 across 63 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 53rd percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29 1
2024 General $2,887 22
2023 General $285 8
2022 General $76 2
2021 General $126 1
2020 General $103 3
2019 General $4,743 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicholas Kenney
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Nicholas Kenney were reported at $29. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Nicholas Kenney Sports Medicine median Middle half National median
2019 $4,743 $1,176 $199–$4,249 $163
2020 $103 $708 $96–$2,890 $114
2021 $126 $1,213 $152–$3,994 $132
2022 $76 $1,230 $159–$3,998 $149
2023 $285 $584 $146–$2,836 $160
2024 $2,887 $628 $163–$3,168 $164
2025 $29 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $6,502 29 payments
  2. Zimmer Biomet Holdings, Inc. $1,246 17 payments
  3. Exactech, Inc. $135 1 payment
  4. Stryker Corporation $127 3 payments
  5. KARL STORZ Endoscopy-America $68 1 payment
  6. Flexion Therapeutics, Inc. $48 3 payments
  7. Avanos Medical $25 2 payments
  8. DePuy Synthes Sales Inc. $17 1 payment
  9. Heron Therapeutics, Inc. $16 1 payment
  10. Vericel Corporation $16 1 payment
  11. Other $47 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,375 1 payment
  2. Travel and Lodging $2,569 12 payments
  3. Food and Beverage $2,304 50 payments
Products named General payments · program years 2019–2025
  1. Acufex $4,315 8 payments
  2. Fast-Fix 360 $4,315 8 payments
  3. BIOSURE REGENESORB $3,479 3 payments
  4. Firstpass $3,479 3 payments
  5. Acufex Director $3,479 3 payments
  6. Bone Anchors with Arthroscopic Delivery System $1,231 5 payments
  7. MICRORAPTOR $1,164 4 payments
  8. Q-FIX $1,164 4 payments
  9. Comprehensive Shoulder System $999 11 payments
  10. Meniscal Root Repair System $836 5 payments
  11. Other $2,328 49 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 18 drugs

Part D claims

920

Median for Orthopedic Surgery: 203

Drug cost

$9,108

Median for Orthopedic Surgery: $1,433

Branded share of claims

30.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 76 $2,788
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 230 $2,373
Pregabalin Generic 53 $789
Ondansetron Hcl Generic 66 $466
Meloxicam Generic 98 $441
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 48 $423
Cyclobenzaprine Hcl Generic 51 $308
Methylprednisolone Generic 65 $302
Doxycycline Hyclate Generic 46 $288
Prednisone Generic 58 $233

The 10 drugs with the highest cost, of 18 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$164,463

Of which drugs: $21,668

Medicare patients

304

Average age 74

Services billed

3,751

174 women, 130 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 31%
Ischemic heart disease 25%
Depression 24%
Chronic kidney disease 21%
Atrial fibrillation 14%
Cancer 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose J7327 Office 20 36 $18,892
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 129 2,297 $1,621

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

63 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record